BioSpace News Archive

Business

Immune Design to Report Third Quarter 2017 Financial Results & Provide Corporate Update

Management will host a webcast and conference call at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time on November 1, 2017.

October 27, 2017
·
1 min read
Business

Sunesis to Host Conference Call on November 2nd to Discuss Third Quarter 2017 Financial Results and Recent Highlights

The company will discuss corporate updates and financial results for the third quarter ended September 30, 2017.

October 27, 2017
·
1 min read
Genetown

NxStage Announces Stockholder Approval Of Merger Agreement With Fresenius Medical Care

NxStage Medical today announced that at a special meeting of stockholders held today, the Company’s stockholders voted to adopt the previously announced Agreement and Plan of Merger, dated August 7, 2017.

October 27, 2017
·
2 min read
Business

Biophytis Appoints Professor Thomas Voit to Scientific Advisory Board to Help Accelerate Pipeline Programs in Orphan Pediatric Diseases

Professor Voit is the Director of the Biomedical Research Centre of the Great Ormond Street Hospital for Children NHS Foundation Trust and the Institute of Child Health, University College London.

October 27, 2017
·
6 min read
Ablynx Announces Full Exercise of Underwriters’ Option to Purchase Additional Shares and End of Stabilization Period

The exercise of the greenshoe option also marks the end of the stabilization period in relation to the initial U.S. public offering.

October 27, 2017
·
5 min read
Business

Dyadic International to Announce Third Quarter 2017 Financial Results and Host Conference Call on Thursday November 9, 2017

A conference call will be held at 5:00 p.m. Eastern Time to discuss those results.

October 27, 2017
·
4 min read
Business

Adaptimmune to Report Third Quarter 2017 Financial Results on November 2, 2017

Management will provide a business update and discuss the financial results for the third quarter of 2017 on the same day.

October 27, 2017
·
2 min read
Microbix Completes Second Tranche of Brokered Private Placement Tranche Gross Proceeds of $1,164,640, Total Proceeds of $3,500,000

Microbix Biosystems Inc. announces that it has completed a second and final tranche of the brokered private placement financing announced on October 19, 2017.

October 27, 2017
·
3 min read
Certara-Monash University Industry Fellowship Program Receives Funding from MTPConnect’s Project Fund Program

It will provide a proposed AUD750,000 provisional funding to the Certara-Monash University Industry Fellowship Program over two years, with proposed matched funding of AUD750,000 coming from Certara®.

October 27, 2017
·
6 min read